{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T13:59:03Z","timestamp":1774965543306,"version":"3.50.1"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2022\/06370-3"],"award-info":[{"award-number":["2022\/06370-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2019\/15654-2"],"award-info":[{"award-number":["2019\/15654-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2020\/08015-0"],"award-info":[{"award-number":["2020\/08015-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2023\/15682-1"],"award-info":[{"award-number":["2023\/15682-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2024\/14294-0"],"award-info":[{"award-number":["2024\/14294-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["103318\/2023-2"],"award-info":[{"award-number":["103318\/2023-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["302527\/2022-2"],"award-info":[{"award-number":["302527\/2022-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.nucmedbio.2025.109052","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:23:22Z","timestamp":1752625402000},"page":"109052","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Brain metabolic and behavioral alterations in a Down syndrome model"],"prefix":"10.1016","volume":"148-149","author":[{"given":"Larissa Estessi","family":"de Souza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara Maria","family":"Righini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitri Brigide de Almeida","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuella Penido","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Lazzarotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Limberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Alberto","family":"Buchpiguel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo Rigon","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline Cristiano","family":"Real","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidia Emmanuela Wiazowski","family":"Spelta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"de Paula Faria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2025.109052_bb0005","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1056\/NEJMra1706537","article-title":"Down syndrome","volume":"382","author":"Bull","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0010","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.046243","article-title":"Longitudinal neuroanatomical and behavioral analyses show phenotypic drift and variability in the Ts65Dn mouse model of down syndrome","volume":"13","author":"Shaw","year":"2020","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-019-0143-7","article-title":"Down syndrome","volume":"6","author":"Antonarakis","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00840","article-title":"Immune defect in adults with down syndrome: insights into a complex issue","volume":"11","author":"Dieudonn\u00e9","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0025","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/CIRCULATIONAHA.122.059706","article-title":"Cardiovascular complications of down syndrome: scoping review and expert consensus","volume":"147","author":"Dimopoulos","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0030","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S1474-4422(21)00245-3","article-title":"Alzheimer\u2019s disease associated with down syndrome: a genetic form of dementia","volume":"20","author":"Fortea","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0035","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1007\/s11064-022-03659-0","article-title":"Cholinergic senescence in the Ts65Dn mouse model for down syndrome","volume":"47","author":"Kirstein","year":"2022","journal-title":"Neurochem Res"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0040","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MED.0000000000000382","article-title":"Endocrine manifestations of Down syndrome","volume":"25","author":"Whooten","year":"2018","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0045","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1001\/jama.2020.17024","article-title":"Medical care of adults with Down syndrome: a clinical guideline","volume":"324","author":"Tsou","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0050","article-title":"Global, regional, and national burden and trends of Down syndrome from 1990 to 2019","volume":"13","author":"Chen","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0055","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00281-020-00804-1","article-title":"Down syndrome, accelerated aging and immunosenescence","volume":"42","author":"Gensous","year":"2020","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2023.111824","article-title":"Cellular senescence and premature aging in Down Syndrome","volume":"212","author":"Peng","year":"2023","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/1440-1681.12896","article-title":"Aging mechanisms and intervention targets","volume":"44","author":"Liu","year":"2017","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0070","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cmet.2012.12.005","article-title":"Adaptive downregulation of mitochondrial function in down syndrome","volume":"17","author":"Helguera","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0075","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nature12558","article-title":"Down\u2019s syndrome link to ageing","volume":"501","author":"Souroullas","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0080","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/acel.12325","article-title":"Accelerated epigenetic aging in Down syndrome","volume":"14","author":"Horvath","year":"2015","journal-title":"Aging Cell"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0085","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ddrr.1128","article-title":"Atypical aging in down syndrome","volume":"18","author":"Zigman","year":"2013","journal-title":"Dev Disabil Res Rev"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0090","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1053\/j.semnuclmed.2021.01.002","article-title":"Brain [F-18]FDG PET for clinical dementia workup: differential diagnosis of Alzheimer\u2019s disease and other types of dementing disorders","volume":"51","author":"Minoshima","year":"2021","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0095","doi-asserted-by":"crossref","first-page":"54","DOI":"10.12779\/dnd.2024.23.1.54","article-title":"The usefulness of 18F-FDG PET to differentiate subtypes of dementia: the systematic review and meta-analysis","volume":"23","author":"Na","year":"2024","journal-title":"Dement Neurocogn Disord"},{"issue":"7","key":"10.1016\/j.nucmedbio.2025.109052_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073785","article-title":"Brain metabolic alterations in Alzheimer\u2019s disease","volume":"23","author":"Ardanaz","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0105","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.2967\/jnumed.121.263194","article-title":"18F-FDG PET imaging in neurodegenerative dementing disorders: insights into subtype classification, emerging disease categories, and mixed dementia with copathologies","volume":"63","author":"Minoshima","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0110","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fnagi.2018.00191","article-title":"Metabolic and vascular imaging biomarkers in down syndrome provide unique insights into brain aging and Alzheimer disease pathogenesis","volume":"10","author":"Head","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0115","first-page":"69","article-title":"Dissociation of Down syndrome and Alzheimer\u2019s disease effects with imaging","volume":"2","author":"Matthews","year":"2016","journal-title":"Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0120","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3233\/JAD-170390","article-title":"PET imaging of tau pathology and relationship to amyloid, longitudinal MRI, and cognitive change in down syndrome: results from the down syndrome biomarker initiative (DSBI)","volume":"60","author":"Rafii","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"3\u20134","key":"10.1016\/j.nucmedbio.2025.109052_bb0125","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000056997","article-title":"Ts65Dn -- localization of the translocation breakpoint and trisomic gene content in a mouse model for Down syndrome","volume":"93","author":"Akeson","year":"2001","journal-title":"Cytogenet Cell Genet"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0130","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00335-011-9321-y","article-title":"Transcript catalogs of human chromosome 21 and orthologous chimpanzee and mouse regions","volume":"22","author":"Sturgeon","year":"2011","journal-title":"Mamm Genome"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0135","unstructured":"Paxinos, G., Franklin, K.B.J. The mouse brain in stereotaxic coordinates. 2nd Edition. San Diego: Academic Press."},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0140","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1093\/hmg\/ddq179","article-title":"A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions","volume":"19","author":"Yu","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0145","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.56223","article-title":"A non-mosaic transchromosomic mouse model of down syndrome carrying the long arm of human chromosome 21","volume":"9","author":"Kazuki","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0150","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1021\/pr2011582","article-title":"Loss of correlations among proteins in brains of the Ts65Dn mouse model of down syndrome","volume":"11","author":"Ahmed","year":"2012","journal-title":"J Proteome Res"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0155","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00335-011-9357-z","article-title":"Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn","volume":"22","author":"Reinholdt","year":"2011","journal-title":"Mamm Genome"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0160","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbr.2009.08.034","article-title":"Behavioral validation of the Ts65Dn mouse model for Down syndrome of a genetic background free of the retinal degeneration mutation Pde6b(rd1)","volume":"206","author":"Costa","year":"2010","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0165","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1177\/0271678X17750351","article-title":"Evaluation of exercise-induced modulation of glial activation and dopaminergic damage in a rat model of Parkinson\u2019s disease using [11C]PBR28 and [18F]FDOPA PET","volume":"39","author":"Real","year":"2019","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/jnr.25327","article-title":"Impact of cannabidiol on brain glucose metabolism of C57Bl\/6 male mice previously exposed to cocaine","volume":"102","author":"Spelta","year":"2024","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0175","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.neuroscience.2005.07.014","article-title":"A three-dimensional digital atlas database of the adult C57BL\/6J mouse brain by magnetic resonance microscopy","volume":"135","author":"Ma","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0180","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neuroimage.2007.06.032","article-title":"A novel approach for imaging brain\u2013behavior relationships in mice reveals unexpected metabolic patterns during seizures in the absence of tissue plasminogen activator","volume":"38","author":"Mirrione","year":"2007","journal-title":"NeuroImage"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0185","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ar.21301","article-title":"Cardiovascular development and survival during gestation in the Ts65Dn mouse model for down syndrome","volume":"294","author":"Lorandeau","year":"2011","journal-title":"Anat Rec"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137093","article-title":"Risk of major cardiovascular events in people with down syndrome","volume":"10","author":"Sobey","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0195","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.12910","article-title":"Association of Alzheimer disease with life expectancy in people with down syndrome","volume":"5","author":"Iulita","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0200","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.freeradbiomed.2017.09.021","article-title":"Increased levels of inflammatory plasma markers and obesity risk in a mouse model of Down syndrome","volume":"114","author":"Fructuoso","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/ajhb.22985","article-title":"Influence of complex childhood diseases on variation in growth and skeletal development","volume":"29","author":"Zemel","year":"2017","journal-title":"Am J Hum Biol"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0210","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bone.2010.09.028","article-title":"Disruption of bone development and homeostasis by trisomy in Ts65Dn down syndrome mice","volume":"48","author":"Blazek","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0215","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1352\/1934-9556-55.5.315","article-title":"Bone mass assessment in a cohort of adults with down syndrome: a cross-sectional study","volume":"55","author":"Costa","year":"2017","journal-title":"Intellect Dev Disabil"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0220","first-page":"287","article-title":"Ultrastructural features of skeletal muscle in adult and aging Ts65Dn mice, a murine model of Down syndrome","volume":"3","author":"Cisterna","year":"2013","journal-title":"Muscles Ligaments Tendons J"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0225","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.nucmedbio.2022.06.007","article-title":"Healthy brain aging assessed with [18F]FDG and [11C]UCB-J PET","volume":"112","author":"Andersen","year":"2022","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0230","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s40478-021-01237-z","article-title":"Forebrain Shh overexpression improves cognitive function and locomotor hyperactivity in an aneuploid mouse model of Down syndrome and its euploid littermates","volume":"9","author":"Gao","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1202208","article-title":"Modeling Alzheimer\u2019s disease related phenotypes in the Ts65Dn mouse: impact of age on a\u03b2, tau, pTau, NfL, and behavior","volume":"17","author":"Overk","year":"2023","journal-title":"Front Neurosci"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0240","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/bph.12169","article-title":"Short-term treatment with the GABAA receptor antagonist pentylenetetrazole produces a sustained pro-cognitive benefit in a mouse model of Down\u2019s syndrome","volume":"169","author":"Colas","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0245","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.pbb.2015.09.002","article-title":"Low dose EGCG treatment beginning in adolescence does not improve cognitive impairment in a down syndrome mouse model","volume":"138","author":"Stringer","year":"2015","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0250","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.nbd.2010.09.009","article-title":"Mitochondrial autophagy in neural function, neurodegenerative disease, neuron cell death, and aging","volume":"43","author":"Batlevi","year":"2011","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0255","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.nlm.2017.02.006","article-title":"Short-term treatment with flumazenil restores long-term object memory in a mouse model of Down syndrome","volume":"140","author":"Colas","year":"2017","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0260","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nn1860","article-title":"Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome","volume":"10","author":"Fernandez","year":"2007","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.nlm.2020.107207","article-title":"Long-term changes in metabolic brain network drive memory impairments in rats following neonatal hypoxia-ischemia","volume":"171","author":"Azevedo","year":"2020","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193140","article-title":"Effects of blood glucose level on 18F-FDG uptake for PET\/CT in normal organs: a systematic review","volume":"13","author":"Sprinz","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0275","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abe5640","article-title":"Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases","volume":"13","author":"Xiang","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0280","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jalz.2018.01.002","article-title":"Early striatal amyloid deposition distinguishes down syndrome and autosomal dominant AD from late onset amyloid deposition","volume":"14","author":"Cohen","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0285","article-title":"Basal forebrain cholinergic neurons: linking Down syndrome and Alzheimer\u2019s disease","volume":"13","author":"Martinez","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0290","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.2967\/jnumed.117.195107","article-title":"Time courses of cortical glucose metabolism and microglial activity across the life span of wild-type mice: a PET study","volume":"58","author":"Brendel","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0295","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0006-8993(02)02500-3","article-title":"Reactivity to object and spatial novelty is normal in older Ts65Dn mice that model Down syndrome and Alzheimer\u2019s disease","volume":"945","author":"Hyde","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0300","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.freeradbiomed.2017.07.026","article-title":"Neurogenesis impairment: an early developmental defect in Down syndrome","volume":"114","author":"Stagni","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0305","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/jpi.12037","article-title":"Long-term oral administration of melatonin improves spatial learning and memory and protects against cholinergic degeneration in middle-aged Ts65Dn mice, a model of Down syndrome","volume":"54","author":"Corrales","year":"2013","journal-title":"J Pineal Res"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0310","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1006\/exnr.1999.7289","article-title":"Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of down\u2019s syndrome","volume":"161","author":"Granholm","year":"2000","journal-title":"Exp Neurol"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0315","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12974-023-02735-8","article-title":"Depletion and activation of microglia impact metabolic connectivity of the mouse brain","volume":"20","author":"Gn\u00f6rich","year":"2023","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0320","first-page":"69","article-title":"Detection of an Alzheimer disease pattern of cerebral metabolism in Down syndrome","volume":"5","author":"Azari","year":"2008","journal-title":"Dementia"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0325","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3233\/JAD-170720","article-title":"Alzheimer-like pattern of hypometabolism emerges with elevated amyloid-\u03b2 Burden in down syndrome","volume":"61","author":"Lao","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0330","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3389\/fmed.2020.00529","article-title":"In vivo imaging with 18F-FDG- and 18F-florbetaben-PET\/MRI detects pathological changes in the brain of the commonly used 5XFAD mouse model of Alzheimer\u2019s disease","volume":"7","author":"Franke","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0335","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1177\/0271678X16677990","article-title":"Brain energy metabolism and neuroinflammation in ageing APP\/PS1-21 mice using longitudinal 18F-FDG and 18F-DPA-714 PET imaging","volume":"37","author":"Takkinen","year":"2017","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0340","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.neurobiolaging.2012.12.027","article-title":"In vivo evaluation of amyloid deposition and brain glucose metabolism of 5XFAD mice using positron emission tomography","volume":"34","author":"Rojas","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116728","article-title":"Brain glucose metabolism: role of nitric oxide","volume":"232","author":"Ghasemi","year":"2025","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0350","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/alz.13538","article-title":"Brain metabolic network covariance and aging in a mouse model of Alzheimer\u2019s disease","volume":"20","author":"Chumin","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbscr.2020.100049","article-title":"Suprachiasmatic lesions restore object recognition in down syndrome model mice","volume":"8","author":"Chuluun","year":"2020","journal-title":"Neurobiology of Sleep and Circadian Rhythms"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2024.120860","article-title":"Astroglial glucose uptake determines brain FDG-PET alterations and metabolic connectivity during healthy aging in mice","volume":"300","author":"Bartos","year":"2024","journal-title":"NeuroImage"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0365","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00335-011-9356-0","article-title":"Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling down syndrome","volume":"22","author":"Duchon","year":"2011","journal-title":"Mamm Genome"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0370","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s00335-016-9661-8","article-title":"Mouse models of Down syndrome: gene content and consequences","volume":"27","author":"Gupta","year":"2016","journal-title":"Mamm Genome"},{"key":"10.1016\/j.nucmedbio.2025.109052_bb0375","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13590","article-title":"Temporal and brain region-specific elevations of soluble amyloid-\u03b240-42 in the Ts65Dn mouse model of Down syndrome and Alzheimer\u2019s disease","volume":"21","author":"Tallino","year":"2022","journal-title":"Aging Cell"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805125000617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805125000617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T13:11:43Z","timestamp":1774962703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805125000617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":75,"alternative-id":["S0969805125000617"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2025.109052","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain metabolic and behavioral alterations in a Down syndrome model","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2025.109052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109052"}}